TechNavio recognizes the following companies as the key players in the Global DNA Sequencing Equipment and Services market: Agilent Technologies Inc., Illumina Inc., Life Technologies Corp., Pacific Biosciences of California Inc., and Roche Holding AG.
Commenting on the report, an analyst from TechNavio’s team said: “One of the main trends witnessed in the Global DNA Sequencing Equipment and Services market is increase in number of DNA sequencing projects. The Global DNA Sequencing Equipment and Services market has recently witnessed a significant increase in the number of projects funded by the leading vendors. For instance, Illumina and Partners HealthCare System Inc. announced a strategic alliance in September 2012, in order to offer infrastructure and networking tools for the interpretation and reporting process on genetic sequencing data. Moreover, Hoffmann-La Roche Ltd. and SoftGenetics LLC signed a co-promotion agreement in May 2012 for a new sequencing software tool. Roche and PerkinElmer Inc. announced a new supply agreement in May 2011 for the distribution of the NimbleGen CGX microarray workflow. In addition, Pacific Biosciences announced collaboration in July 2012, with Imec, a Belgium-based nanoelectronics research center focusing on the improvement of innovative microchips for multiplexed single-molecule genetic analysis.”
According to the report, one of the main factors driving the market is success of HGP. The HGP is an international scientific research project to regulate DNA sequences of the human body and to map the genes. The success of the HGP has led to a better understanding of human evolution. The effect of the HGP can help in the genotyping of specific viruses to direct suitable cure, identification of oncogenes and mutations in cancer, development of forensic applied sciences, and risk valuation.
Further, the report states that one of the main challenges is low adoption of genomic technology. Adoption of genomic technology remains low compared to other sequence analysis technologies, especially among large biotechnology companies. Researchers still have doubts over the advantages of genomic technology, mainly because of a few instances of failure during genomic research programs.
The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are 23andMe Inc., Accelrys Inc., AltheaDx Inc., Ambry Genetics Corp., Asuragen Inc., Base4 Innovation Ltd., BGI, Biomatters Ltd., BioNano Genomics Inc., Biotique Systems Inc., Danaher Corp., DNA Electronics Ltd., DNAnexus Inc., DNASTAR Inc., DNAVision SA, Eurofins Scientific SA, Fluidigm Corp., Foundation Medicine Inc., GATC Biotech AG, GE Healthcare Ltd., GenapSys Inc., Genia Corp., Genomatix Software GmbH, GenomeQuest Inc., Genomic Health Inc., Good Start Genetics Inc., HelicosBioSciences Corp., IBM Corp., IntegenX Inc., Knome Inc., Laboratory Corp. of America Holdings, Macrogen Inc., Oxford Nanopore Technologies Ltd., PerkinElmer Inc., QIAGEN N.V., RainDance Technologies Inc., Sequenom Inc., Siemens Healthcare, Source BioScience plc, TheragenEtex Co. Ltd., Transgenomic Inc., and Trovagene Inc..
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/report/global-dna-sequencing-equipment-and-serv…
TechNavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our market research, please visit https://www.technavio.com/healthcare-chemicals-food-retail
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Research Report – Global DNA Sequencing Equipment and Services Market 2012-2016
